Influenza vaccination in subjects with α1-antitrypsin deficiency

Chest

Volumn 133, Issue 1, 2008, Pages 49-55

  Campos, Michael A ^a   Alazemi, Saleh ^a   Zhang, Guoyan ^b   Sandhaus, Robert A ^c   Wanner, Adam ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Miami Dade Health Department   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Influenza vaccines; Outcome assessment (health care); Pulmonary disease, chronic obstructive; 1 antitrypsin deficiency

Indexed keywords

INFLUENZA VACCINE;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; DISEASE EXACERBATION; DISEASE SEVERITY; FOLLOW UP; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNITED STATES;

EID: 38349053915     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-1482     Document Type: Article

References (28)

1. Simonsen L, Clarke MJ, Williamson GD, et al. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997; 87:1944-1950
2. Smith NM, Bresee JS, Shay DK, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2006; 55: 1-42
3. Govaert TM, Thijs CT, Masurel N, et al. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA 1994; 272:1661-1665
4. Hak E, Nordin J, Wei F, et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis 2002; 35:370-577
5. Jefferson T, Rivetti D, Rivetti A, et al. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005; 366:1165-1174
6. Centers for Disease Control and Prevention. Estimates of influenza vaccination target population sizes in 2006 and recent vaccine uptake levels. Available at: www.cdc.gov/flu/ professionals/vaccination. Accessed May 14, 2007
7. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease. Available at: www. goldcopd.org. Accessed July 17, 2007
8. Howells CH, Tyler LE. Prophylactic use of influenza vaccine in patients with chronic bronchitis: a pilot trial. Lancet 1961; 2:1428-1432
9. Fell PJ, Watson NP, O'Donnell HF, et al. Longer term effects of live influenza vaccine in patients with chronic pulmonary disease. Lancet 1977; 1:1282-1284
10. Fox R, French N, Davies L, et al. Influenza immunization status and viral respiratory tract infections in patients with chronic airflow limitation. Respir Med 1995; 89:559-561
11. Hak E, van Essen GA, Buskens E, et al. Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands. J Epidemiol Community Health 1998; 52:120-125
12. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999; 130:397-403
13. Wongsurakiat P, Maranetra KN, Wasi C, et al. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 2004; 125:2011-2020
14. Hak E, Hoes AW, Grobbee DE, et al. Conventional influenza vaccination is not associated with complications in working-age patients with asthma or chronic obstructive pulmonary disease. Am J Epidemiol 2003; 157:692-700
15. Rohde G, Wiethege A, Borg I, et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 2003; 58:37-42
16. Ko FW, Ip M, Chan PK, et al. A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD. Chest 2007; 131:44-52
17. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:1418-1422
18. Burrows B, Bloom JW, Traver GA, et al. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987; 317:1309-1314
19. 1-antitrypsin deficiency between 1968 and 2003. Chest 2005; 128:1179-1186
20. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with α-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168:818-900
21. Update: influenza activity - United States and worldwide, 2003-04 season, and composition of the 2004-05 influenza vaccine. MMWR Morb Mortal Wkly Rep 2004; 53:547-552
22. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000; 117:398S-401S
23. Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106:196-204
24. Plans-Rubió P. Prevention and control of influenza in persons with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulm Dis 2007; 2:41-53
25. Jimenez-Garcia R, Arinez-Fernandez MC, Hernandez-Barrera V, et al. Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical practitioners in Catalonia, Spain. J Infect 2007; 54:65-74
26. Poole PJ, Chacko E, Wood-Baker RW, et al. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; CD002733
27. Harper SA, Fukuda K, Uyeki TM, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2004; 53:1-40
28. 1-antitrypsin deficiency. Eur Respir J 2005; 25:992-1000